Go Pro

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Brainsway Ltd. Sponsored ADR stock logo
BWAY
Brainsway
$13.45
-1.3%
$14.86
$7.14
$17.40
$548.04M1.2581,699 shs90,424 shs
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
$15.96
-2.7%
$15.24
$8.12
$17.42
$569.06M0.57369,049 shs279,457 shs
FOCL
FocalTherics
$4.74
+11.0%
$4.93
$1.75
$6.40
$177.88M-0.0772,487 shs143,075 shs
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
$22.33
-1.9%
$22.40
$14.42
$26.74
$594.26M0.99205,665 shs99,033 shs
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Brainsway Ltd. Sponsored ADR stock logo
BWAY
Brainsway
-1.32%-0.07%-5.21%-7.50%+75.13%
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
-2.68%-1.60%-4.72%+29.55%+45.09%
FOCL
FocalTherics
+11.01%+16.46%+13.40%-6.14%+473,999,900.00%
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
-1.89%-3.54%-10.93%+13.81%+17.90%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Brainsway Ltd. Sponsored ADR stock logo
BWAY
Brainsway
$13.45
-1.3%
$14.86
$7.14
$17.40
$548.04M1.2581,699 shs90,424 shs
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
$15.96
-2.7%
$15.24
$8.12
$17.42
$569.06M0.57369,049 shs279,457 shs
FOCL
FocalTherics
$4.74
+11.0%
$4.93
$1.75
$6.40
$177.88M-0.0772,487 shs143,075 shs
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
$22.33
-1.9%
$22.40
$14.42
$26.74
$594.26M0.99205,665 shs99,033 shs
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Brainsway Ltd. Sponsored ADR stock logo
BWAY
Brainsway
-1.32%-0.07%-5.21%-7.50%+75.13%
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
-2.68%-1.60%-4.72%+29.55%+45.09%
FOCL
FocalTherics
+11.01%+16.46%+13.40%-6.14%+473,999,900.00%
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
-1.89%-3.54%-10.93%+13.81%+17.90%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Brainsway Ltd. Sponsored ADR stock logo
BWAY
Brainsway
2.71
Moderate Buy$18.2035.32% Upside
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
2.86
Moderate Buy$23.1745.15% Upside
FOCL
FocalTherics
2.40
Hold$7.7563.50% Upside
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
2.73
Moderate Buy$26.4418.43% Upside

Current Analyst Ratings Breakdown

Latest FOCL, KIDS, DCTH, and BWAY Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
9/14/2026
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
Reiterated RatingBuy$29.00
9/10/2026
Brainsway Ltd. Sponsored ADR stock logo
BWAY
Brainsway
Reiterated RatingBuy$20.00
9/8/2026
Brainsway Ltd. Sponsored ADR stock logo
BWAY
Brainsway
Reiterated RatingBuy$19.00
9/4/2026
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
UpgradeSell (D)Sell (D+)
8/31/2026
Brainsway Ltd. Sponsored ADR stock logo
BWAY
Brainsway
Boost Price TargetBuy$17.00 ➝ $19.00
8/25/2026
FOCL
FocalTherics
Reiterated RatingBuy$10.00
8/21/2026
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
DowngradeSell (D+)Sell (D)
8/20/2026
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
Boost Price TargetBuy$24.00 ➝ $29.00
8/19/2026
Brainsway Ltd. Sponsored ADR stock logo
BWAY
Brainsway
DowngradeBuy (B-)Hold (C+)
8/17/2026
FOCL
FocalTherics
Reiterated RatingSell (D-)
8/14/2026
FOCL
FocalTherics
Reiterated RatingNeutral$4.00
(Data available from 9/24/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Brainsway Ltd. Sponsored ADR stock logo
BWAY
Brainsway
$60.70M8.91$0.23 per share58.22$1.87 per share7.19
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
$95.42M5.80$0.05 per share313.73$3.15 per share5.07
FOCL
FocalTherics
$79.31M2.24N/AN/A$0.52 per share9.12
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
$236.35M2.47$0.16 per share136.87$13.82 per share1.62
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Brainsway Ltd. Sponsored ADR stock logo
BWAY
Brainsway
$7.57M$0.4430.5723.60N/A15.65%12.74%8.17%11/10/2026 (Estimated)
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
$2.70M$0.011,597.60133.00N/A0.56%0.46%0.42%11/3/2026 (Estimated)
FOCL
FocalTherics
-$29.25M-$1.03N/AN/AN/A-56.26%-248.00%-44.69%N/A
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
-$39.65M-$1.68N/AN/AN/A-15.72%-8.10%-5.54%10/27/2026 (Estimated)

Latest FOCL, KIDS, DCTH, and BWAY Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/14/2026Q2 2026
FOCL
FocalTherics
-$0.20-$0.39-$0.19-$0.39N/A$13.20 million
8/12/2026Q2 2026
Brainsway Ltd. Sponsored ADR stock logo
BWAY
Brainsway
$0.10$0.14+$0.04$0.07$16.54 million$17.11 million
8/6/2026Q2 2026
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
-$0.0891$0.07+$0.1591$0.07$26.25 million$29.13 million
8/4/2026Q2 2026
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
-$0.3022-$0.26+$0.0422-$0.30$68.21 million$70.51 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Brainsway Ltd. Sponsored ADR stock logo
BWAY
Brainsway
N/AN/AN/AN/AN/A
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
N/AN/AN/AN/AN/A
FOCL
FocalTherics
N/AN/AN/AN/AN/A
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Brainsway Ltd. Sponsored ADR stock logo
BWAY
Brainsway
N/A
3.59
3.27
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
N/A
9.83
8.95
FOCL
FocalTherics
1.79
1.60
1.38
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
0.28
4.78
2.17

Institutional Ownership

CompanyInstitutional Ownership
Brainsway Ltd. Sponsored ADR stock logo
BWAY
Brainsway
30.11%
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
61.12%
FOCL
FocalTherics
62.74%
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
69.05%

Insider Ownership

CompanyInsider Ownership
Brainsway Ltd. Sponsored ADR stock logo
BWAY
Brainsway
19.00%
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
19.36%
FOCL
FocalTherics
10.10%
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
32.50%
CompanyEmployeesShares OutstandingFree FloatOptionable
Brainsway Ltd. Sponsored ADR stock logo
BWAY
Brainsway
12940.21 million32.57 millionNot Optionable
Delcath Systems, Inc. stock logo
DCTH
Delcath Systems
15634.70 million27.98 millionOptionable
FOCL
FocalTherics
23037.53 million33.74 millionN/A
OrthoPediatrics Corp. stock logo
KIDS
OrthoPediatrics
60226.11 million17.62 millionOptionable

Recent News About These Companies

OrthoPediatrics Surpasses 1,000 PNP Tibia Nail Implantations
OrthoPediatrics' (KIDS) Buy Rating Reiterated at BTIG Research
How Orthopediatrics Corp. (KIDS) Affects Rotational Strategy Timing
OrthoPediatrics (KIDS) Crosses $70M as Guidance Climbs Higher

New MarketBeat Followers Over Time

Media Sentiment Over Time

Brainsway stock logo

Brainsway NASDAQ:BWAY

$13.45 -0.18 (-1.32%)
Closing price 09/23/2026 04:00 PM Eastern
Extended Trading
$13.40 -0.05 (-0.36%)
As of 04:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company serves doctors, hospitals, and medical centers in the field of psychiatry. BrainsWay Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel.

Delcath Systems stock logo

Delcath Systems NASDAQ:DCTH

$15.96 -0.44 (-2.68%)
Closing price 09/23/2026 04:00 PM Eastern
Extended Trading
$15.98 +0.02 (+0.13%)
As of 07:37 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. Its clinical development program for HEPZATO is the FOCUS clinical trial for patients with metastatic hepatic dominant Uveal Melanoma to investigate objective response rate in metastatic uveal melanoma. It also provides HEPZATO as a stand-alone medical device under the CHEMOSAT Hepatic Delivery System trade name for Melphalan or CHEMOSAT for medical centers to treat a range of liver cancers in Europe. Delcath Systems, Inc. was incorporated in 1988 and is headquartered in New York, New York.

FocalTherics NASDAQ:FOCL

$4.74 +0.47 (+11.01%)
As of 09/23/2026 04:00 PM Eastern

EDAP TMS S.A., together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. It operates in three segments: High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST). The HIFU segment develops, manufactures, and markets medical devices based on HIFU technology for the minimally invasive treatment of urological and other clinical indications. This segment also offers Ablatherm, an ultrasound guided robotic HIFU device for the treatment of organ-confined prostate cancer; Ablatherm Fusion that incorporates the company's proprietary fusion software, which merges MRI and ultrasound images; and the Focal One, a HIFU robotic device dedicated to the focal therapy of prostate cancer, as well as disposables, and leasing and treatment related services; and maintenance services. The ESWL division manufactures, markets, and services lithotripter for the treatment of urinary tract stones by means of ESWL technology; and offers Sonolith i-move, an extracorporeal shockwave lithotripter to small and mid-size hospitals, as well as sells disposable parts for lithotripters and electrodes. The Distribution division markets, distributes, and services lasers, micro-ultrasound systems, and other medical products from third parties, as well as leases devices; sells disposables and spare parts; and offers maintenance services. The company markets and sells its products through its direct marketing, sales organization, and service platform, as well as through third-party distributors and agents. Its customers include hospitals, urology clinics, and research institutions. The company was incorporated in 1979 and is headquartered in Lyon, France.

OrthoPediatrics stock logo

OrthoPediatrics NASDAQ:KIDS

$22.33 -0.43 (-1.89%)
Closing price 09/23/2026 04:00 PM Eastern
Extended Trading
$22.34 +0.02 (+0.07%)
As of 09/23/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Pediguard, Pediatric Nailing Platform | Femur, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIMTM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIROTM Growth Modulation System, PNP Tibia System, ApiFix Mid-C System, and Mitchell Ponseti. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.